Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Thorax|October 11, 2024
Association of fluoroquinolones with the risk of spontaneous pneumothorax: nationwide case-time-control studyAnne Bénard-Laribière, Elodie Pambrun, Serge Kouzan, et al.
European Journal of Epidemiology|September 21, 2022
Impact of the COVID-19 pandemic and its control measures on cardiovascular and antidiabetic drugs use in France in 2020: a nationwide repeated cohort studyClément Mathieu, Elodie Pambrun, Anne Bénard-Laribière, et al.
European Journal of Clinical Pharmacology|March 30, 2016
Comorbidities and concurrent medications increasing the risk of adverse drug reactions: prevalence in French benzodiazepine usersAnne Bénard-Laribière, Pernelle Noize, Elodie Pambrun, et al.
Pharmacoepidemiology and Drug Safety|November 4, 2016
Trends in incident use of benzodiazepines and Z-drugs in France from 2006 to 2012: a population-based studyAnne Bénard-Laribière, Pernelle Noize, Elodie Pambrun, et al.
European Journal of Clinical Pharmacology|January 8, 2018
Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of usersFrançois Montastruc, Anne Bénard-Laribière, Pernelle Noize, et al.
The Journal of Clinical Psychiatry|April 7, 2015
Impact of prenatal exposure to psychotropic drugs on neonatal outcome in infants of mothers with serious psychiatric illnessesAnne-Laure Sutter-Dallay, Mélanie Bales, Elodie Pambrun, et al.
Archives of Women'S Mental Health|May 13, 2020
Impact of pregnancy on antidepressant treatment course: a population-based comparative cohort study in FranceAnne Bénard-Laribière, Elodie Pambrun, Anne-Laure Sutter-Dallay, et al.
Plos One|December 11, 2012
HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patientsFlorence Abravanel, Stéphanie Raymond, Elodie Pambrun, et al.
Pageof 3